1. Home
  2. CALC vs TPCS Comparison

CALC vs TPCS Comparison

Compare CALC & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • TPCS
  • Stock Information
  • Founded
  • CALC 2011
  • TPCS 1956
  • Country
  • CALC United States
  • TPCS United States
  • Employees
  • CALC N/A
  • TPCS N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • TPCS Metal Fabrications
  • Sector
  • CALC Health Care
  • TPCS Industrials
  • Exchange
  • CALC Nasdaq
  • TPCS Nasdaq
  • Market Cap
  • CALC 36.0M
  • TPCS 29.7M
  • IPO Year
  • CALC N/A
  • TPCS N/A
  • Fundamental
  • Price
  • CALC $2.51
  • TPCS $3.08
  • Analyst Decision
  • CALC Strong Buy
  • TPCS
  • Analyst Count
  • CALC 5
  • TPCS 0
  • Target Price
  • CALC $18.20
  • TPCS N/A
  • AVG Volume (30 Days)
  • CALC 32.4K
  • TPCS 21.3K
  • Earning Date
  • CALC 03-27-2025
  • TPCS 01-21-2025
  • Dividend Yield
  • CALC N/A
  • TPCS N/A
  • EPS Growth
  • CALC N/A
  • TPCS N/A
  • EPS
  • CALC N/A
  • TPCS N/A
  • Revenue
  • CALC N/A
  • TPCS $33,182,059.00
  • Revenue This Year
  • CALC N/A
  • TPCS N/A
  • Revenue Next Year
  • CALC N/A
  • TPCS N/A
  • P/E Ratio
  • CALC N/A
  • TPCS N/A
  • Revenue Growth
  • CALC N/A
  • TPCS 6.44
  • 52 Week Low
  • CALC $2.05
  • TPCS $2.85
  • 52 Week High
  • CALC $6.27
  • TPCS $5.95
  • Technical
  • Relative Strength Index (RSI)
  • CALC 39.62
  • TPCS 41.58
  • Support Level
  • CALC $2.37
  • TPCS $3.04
  • Resistance Level
  • CALC $2.75
  • TPCS $3.19
  • Average True Range (ATR)
  • CALC 0.22
  • TPCS 0.13
  • MACD
  • CALC 0.00
  • TPCS 0.01
  • Stochastic Oscillator
  • CALC 26.17
  • TPCS 12.07

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.

Share on Social Networks: